as 08-01-2025 4:00pm EST
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
Upcoming Earnings Alert:
Get ready for potential market movements as SIGA Technologies Inc. SIGA prepares to release earnings report on 05 Aug 2025.
Founded: | 1995 | Country: | United States |
Employees: | N/A | City: | NEW YORK |
Market Cap: | 515.1M | IPO Year: | 1997 |
Target Price: | N/A | AVG Volume (30 days): | 328.2K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | Dividend Payout Frequency: | Annual | |
EPS: | 0.67 | EPS Growth: | -39.12 |
52 Week Low/High: | $4.95 - $12.83 | Next Earning Date: | 08-05-2025 |
Revenue: | $120,330,310 | Revenue Growth: | -23.37% |
Revenue Growth (this year): | -10.61% | Revenue Growth (next year): | 95.31% |
SIGA Breaking Stock News: Dive into SIGA Ticker-Specific Updates for Smart Investing
Zacks
23 days ago
Zacks
a month ago
Zacks
a month ago
Simply Wall St.
2 months ago
Zacks
2 months ago
Simply Wall St.
3 months ago
Simply Wall St.
3 months ago
Simply Wall St.
3 months ago
The information presented on this page, "SIGA SIGA Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.